IGIMS Patna set for expansion with Rs 1,050 crore investment

Published On 2025-05-25 06:00 GMT | Update On 2025-05-25 06:00 GMT

Patna: The state government is set to invest Rs 1,050 crore in a major overhaul of the Indira Gandhi Institute of Medical Sciences (IGIMS), Patna, aiming to develop it into a leading super-speciality hospital in eastern India.

Bihar Health Minister Mangal Pandey said the plan to rejuvenate Indira Gandhi Institute of Medical Sciences (IGIMS) at a total cost of Rs 1,050 crore, was in the final stage.

While laying foundation stone for construction of various infrastructure projects, Pandey said here on Friday that the state government has made a provision of Rs 1,050 crore to develop IGIMS as a super specialty hospital of eastern India.

Out of these, a plan of Rs 750 crore has been prepared and will be inaugurated next month, while plans of Rs 300 crore have been approved by the government and will be completed in the next few months, he added, reports UNI.

The minister said the number of seats for MBBS studies in IGIMS has increased to 150.

Also Read:Bihar CM inaugurates 500-bed hospital building at IGIMS, expanding capacity to 1700

As many as 1,700 beds were available and 1700 more new beds were being arranged with which the number of beds would increase to 3,400.

In addition to the medical facilities, a multi-level parking would be made at IGIMS at an expenditure of Rs 76.47 crore.

According to a UNI report, he said that apart from this, a lecture theatre would be constructed at a cost of Rs 96.36 crore, a hostel for MBBS students at an expenditure of Rs 18.45 crore and an eight-storey dental hospital building would be made in the IGIMS campus at Rs 91.70 crore.

A children's cancer ward, two ultra-modern operation theatres, a 20-bed Creative Care Medicine unit, ultra-modern physiotherapy and dialysis machines will be inaugurated at IGIMS in June.

Also Read:Bihar to set up newborn child care units at district level, says Minister Mangal Pandey

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Kajal Rajput

Kajal joined Medical Dialogue in 2019 for the Latest Health News. She has done her graduation from the University of Delhi. She mainly covers news about the Latest Healthcare. She can be contacted at editorial@medicaldialogues.in.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .